Literature DB >> 1368867

Thom Award Lecture. Trends in the search for bioactive microbial metabolites.

S Omura1.   

Abstract

Bioactive microbial metabolites are attracting increasing attention as useful agents for medicine, veterinary medicine, agriculture, and as unique biochemical tools. A review of the current trends in the discovery of new metabolites shows that the number of active compounds with non-antibiotic type of activity has increased, resulting in an expansion of the variety of bioactivity of microbial metabolites. Factors that contribute to the increased rate of discovery include: development of new methods for activity measurement, exploitation of novel groups of microorganisms as sources of active compounds, new directions for chemical modification, and incorporation of newer knowledge of biotechnology into screening systems. To exemplify this, typical screening methods, and chemical and biological properties of several bioactive compounds obtained by these methods are discussed.

Mesh:

Substances:

Year:  1992        PMID: 1368867     DOI: 10.1007/bf01569759

Source DB:  PubMed          Journal:  J Ind Microbiol        ISSN: 0169-4146


  107 in total

1.  Antibiotics from basidiomycetes. XLI. Clavicoronic acid, a novel inhibitor of reverse transcriptases from Clavicorona pyxidata (Pers. ex Fr.) Doty.

Authors:  G Erkel; T Anke; A Gimenez; W Steglich
Journal:  J Antibiot (Tokyo)       Date:  1992-01       Impact factor: 2.649

2.  Novel cytocidal antibiotics, glucopiericidinols A1 and A2. Taxonomy, fermentation, isolation, structure elucidation and biological characteristics.

Authors:  S Funayama; M Ishibashi; Y Anraku; M Miyauchi; H Mori; K Komiyama; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1989-12       Impact factor: 2.649

3.  Inhibition of acyl-CoA synthetase by triacsins.

Authors:  H Tomoda; K Igarashi; S Omura
Journal:  Biochim Biophys Acta       Date:  1987-10-17

4.  Kitasatosporia, a genus of the order Actinomycetales.

Authors:  Y Takahashi; S Omura
Journal:  Kitasato Arch Exp Med       Date:  1987-06

Review 5.  Philosophy of new drug discovery.

Authors:  S Omura
Journal:  Microbiol Rev       Date:  1986-09

6.  The erythromycin derivative EM-523 is a potent motilin agonist in man and in rabbit.

Authors:  I Depoortere; T L Peeters; G Vantrappen
Journal:  Peptides       Date:  1990 May-Jun       Impact factor: 3.750

7.  Structures of jietacines: unique alpha,beta-unsaturated azoxy antibiotics.

Authors:  N Imamura; H Kuga; K Otoguro; H Tanaka; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1989-01       Impact factor: 2.649

8.  Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain.

Authors:  S Omura; H Ikeda; F Malpartida; H M Kieser; D A Hopwood
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

9.  F-244 specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A synthase.

Authors:  H Tomoda; H Kumagai; H Tanaka; S Omura
Journal:  Biochim Biophys Acta       Date:  1987-12-14

10.  Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.

Authors:  Y Uehara; M Hori; T Takeuchi; H Umezawa
Journal:  Jpn J Cancer Res       Date:  1985-08
View more
  12 in total

1.  From the New Editor-in-Chief.

Authors:  Ramon Gonzalez
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01       Impact factor: 3.346

2.  Antibacterial metabolites from the Actinomycete Streptomyces sp. P294.

Authors:  Huining Su; Hongwei Shao; Keqin Zhang; Guohong Li
Journal:  J Microbiol       Date:  2016-02-02       Impact factor: 3.422

3.  Intracellular screen to identify metagenomic clones that induce or inhibit a quorum-sensing biosensor.

Authors:  Lynn L Williamson; Bradley R Borlee; Patrick D Schloss; Changhui Guan; Heather K Allen; Jo Handelsman
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

4.  Rapid analysis of antibiotic-containing mixtures from fermentation broths by using liquid chromatography-electrospray ionization-mass spectrometry and matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry.

Authors:  B L Ackermann; B T Regg; L Colombo; S Stella; J E Coutant
Journal:  J Am Soc Mass Spectrom       Date:  1996-12       Impact factor: 3.109

Review 5.  The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics.

Authors:  I Chopra; J Hodgson; B Metcalf; G Poste
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Growth and cyclosporin A production by an indigenously isolated strain of Tolypocladium inflatum.

Authors:  K Balakrishnan; A Pandey
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

7.  Identifying the Biosynthetic Gene Cluster for Triacsins with an N-Hydroxytriazene Moiety.

Authors:  Frederick F Twigg; Wenlong Cai; Wei Huang; Joyce Liu; Michio Sato; Tynan J Perez; Jiaxin Geng; Moriel J Dror; Ismael Montanez; Tate L Tong; Hyunsu Lee; Wenjun Zhang
Journal:  Chembiochem       Date:  2019-03-18       Impact factor: 3.164

8.  Antagonistic potential of native strain Streptomyces aurantiogriseus VSMGT1014 against sheath blight of rice disease.

Authors:  Hariharan Harikrishnan; Vellasamy Shanmugaiah; Natesan Balasubramanian; Mahaveer P Sharma; Simeon O Kotchoni
Journal:  World J Microbiol Biotechnol       Date:  2014-10-11       Impact factor: 3.312

9.  Mechanistic studies and biological activity of bioxalomycin alpha 2, a novel antibiotic produced by Streptomyces viridodiastaticus subsp. "litoralis" LL-31F508.

Authors:  M P Singh; P J Petersen; N V Jacobus; W M Maiese; M Greenstein; D A Steinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry.

Authors:  Tobias Kind; Oliver Fiehn
Journal:  BMC Bioinformatics       Date:  2007-03-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.